Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization

Clairvoyant on target for potential commercialization of psilocybin treatment in 2025

Related Keywords

United Kingdom ,Vancouver ,British Columbia ,Canada ,Canadian ,Damian Kettlewell ,Frank Xavier Scheuermeyer ,Maria Eugenia Socias ,Amanda Slaunwhite ,Zizhan Cui ,Alexis Crabtree ,Nadia Fairbairn ,Seonaid Nolan ,Clairvoyant Therapeutics Inc ,World Health Organization ,Life Sciences ,Alcohol Use Disorder ,Global Status Report ,Status Report ,Eugenia Socias ,Wing Yin Mok ,Clairvoyant Therapeutics ,